SDC1 and neoplasm: Based on this, we hypothesize that increasing the tumor cell content in samples as much as practically possible (i.e., optimal bone marrow aspirates and enrichment of CD138+ plasma cells) may compensate for SHM and improve clonality detection rates beyond 95%.